Inactive Instrument

Press Releases Lansen Pharmaceutical Holdings Limited

Equities

503 KYG5380M1033

Press Releases

Unlock all the news: Be the first to know and act before the market!

Lansen Pharmaceutical : FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 31 MAY 2021	21-04-29	PU
Lansen Pharmaceutical : PROPOSAL FOR RE-ELECTION OF DIRECTORS, GENERAL MANDATES TO ISSUE SHARES, AND REPURCHASE SHARES AND NOTICE OF ANNUAL GENERAL MEETING	21-04-29	PU
Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	21-04-15	PU
Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	20-07-23	PU
Lansen Pharmaceutical : CLARIFICATION ANNOUNCEMENT REVISED VOLUNTARY ANNOUNCEMENT IN RESPECT OF THE INFLUENCE OF THE NOVEL CORONAVIRUS	20-02-12	PU
Lansen Pharmaceutical : VOLUNTARY ANNOUNCEMENT IN RESPECT OF THE INFLUENCE OF THE NOVEL CORONAVIRUS	20-02-11	PU
Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	19-12-12	PU
Lansen Pharmaceutical : RESIGNATION OF NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF REMUNERATION COMMITTEE, AUDIT COMMITTEE AND EXECUTIVE COMMITTEE	19-10-31	PU
Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	19-09-25	PU
Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	19-09-18	PU
Lansen Pharmaceutical : VOLUNTARY ANNOUNCEMENT IN RELATION TO FIFTH SHARE REDUCTION PLAN OF STARRY	19-09-11	PU
Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	19-09-10	PU
Lansen Pharmaceutical : LETTER TO SHAREHOLDERS AND CHANGE REQUEST FORM	19-09-10	PU
Lansen Pharmaceutical : LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM	19-09-10	PU
Lansen Pharmaceutical : POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 13 JULY 2016	16-07-13	PU
Lansen Pharmaceutical : FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON 13 JULY 2016	16-06-28	PU
Lansen Pharmaceutical : CONNECTED AND DISCLOSEABLE TRANSACTION IN RELATION TO THE SECOND TRANCHE SUBSCRIPTION IN HAOTIAN HOLDINGS LIMITED AND CONTINUING CONNECTED AND DISCLOSEABLE TRANSACTION IN RELATION TO THE CROSS GUARA	16-06-28	PU
Lansen Pharmaceutical : NOTICE OF EXTRAORDINARY GENERAL MEETING	16-06-28	PU
Lansen Pharmaceutical : CONNECTED AND DISCLOSABLE TRANSACTION IN RELATION TO THE SECOND TRANCHE SUBSCRIPTION IN HAOTIAN HOLDINGS LIMITED AND CONTINUING CONNECTED AND DISCLOSEABLE TRANSACTION IN RELATION TO THE CROSS GUARANTE	16-06-26	PU
Lansen Pharmaceutical : POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 21 June 2016	16-06-23	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Lansen Pharmaceutical Holdings Limited

Equities

503

KYG5380M1033

Press Releases

Filters